154 related articles for article (PubMed ID: 29337085)
21. Ceftaroline fosamil for the treatment of hospital-acquired pneumonia and ventilator-associated pneumonia.
Kaye KS; Udeani G; Cole P; Friedland HD
Hosp Pract (1995); 2015; 43(3):144-9. PubMed ID: 25956849
[TBL] [Abstract][Full Text] [Related]
22. Ceftaroline fosamil: a novel broad-spectrum cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Jorgenson MR; DePestel DD; Carver PL
Ann Pharmacother; 2011 Nov; 45(11):1384-98. PubMed ID: 22009993
[TBL] [Abstract][Full Text] [Related]
23. Ceftaroline for complicated skin and skin-structure infections.
Nannini EC; Stryjewski ME; Corey GR
Expert Opin Pharmacother; 2010 May; 11(7):1197-206. PubMed ID: 20402556
[TBL] [Abstract][Full Text] [Related]
24. Rate and Incidence of Adverse Reactions Associated With Ceftaroline Exposure: Importance of Cutaneous Manifestations.
Jansen JW; Moenster RP
Ann Pharmacother; 2018 Mar; 52(3):235-239. PubMed ID: 28980484
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Neutropenia Associated with Ceftaroline or Ceftriaxone in Patients Receiving at Least 7 Days of Therapy for Severe Infections.
Veve MP; Stuart M; Davis SL
Pharmacotherapy; 2019 Aug; 39(8):809-815. PubMed ID: 31257604
[TBL] [Abstract][Full Text] [Related]
26. A Multicenter, Randomized, Observer-blinded, Active-controlled Study to Evaluate the Safety and Efficacy of Ceftaroline Versus Comparator in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infection.
Korczowski B; Antadze T; Giorgobiani M; Stryjewski ME; Jandourek A; Smith A; O'Neal T; Bradley JS
Pediatr Infect Dis J; 2016 Aug; 35(8):e239-47. PubMed ID: 27164462
[TBL] [Abstract][Full Text] [Related]
27. In vivo emergence of ceftaroline resistance during therapy for MRSA vertebral osteomyelitis.
Sanchez EH; Mendes RE; Sader HS; Allison GM
J Antimicrob Chemother; 2016 Jun; 71(6):1736-8. PubMed ID: 26861570
[No Abstract] [Full Text] [Related]
28. Ceftaroline for Central Nervous System Infections: Case Report of a Young Infant, and Scoping Review.
Urbach H; Sileo N; Lerma S; Nguyen K; Sosa Soto G; Nielsen M; Heiderich A; Holsapple J; Vuppula S; Campbell JI
Pediatr Infect Dis J; 2024 Jul; 43(7):663-668. PubMed ID: 38451889
[TBL] [Abstract][Full Text] [Related]
29. Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery.
Balouch MA; Bajwa RJ; Hassoun A
J Antimicrob Chemother; 2015 Feb; 70(2):624-5. PubMed ID: 25274007
[No Abstract] [Full Text] [Related]
30. Summary of ceftaroline fosamil clinical trial studies and clinical safety.
File TM; Wilcox MH; Stein GE
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S173-80. PubMed ID: 22903949
[TBL] [Abstract][Full Text] [Related]
31. Ceftaroline - a cause for neutropenia.
Rimawi RH; Frenkel A; Cook PP
J Clin Pharm Ther; 2013 Aug; 38(4):330-2. PubMed ID: 23590618
[TBL] [Abstract][Full Text] [Related]
32. Antimicrobial Activity of Ceftaroline Tested against Staphylococcus aureus from Surgical Skin and Skin Structure Infections in US Medical Centers.
Sader HS; Farrell DJ; Flamm RK; Jones RN
Surg Infect (Larchmt); 2016 Aug; 17(4):443-7. PubMed ID: 26990170
[TBL] [Abstract][Full Text] [Related]
33. Ceftaroline for the treatment of methicillin-resistant
White BP; Barber KE; Stover KR
Am J Health Syst Pharm; 2017 Feb; 74(4):201-208. PubMed ID: 28179245
[TBL] [Abstract][Full Text] [Related]
34.
Gaikwad V; Gohel T; Panickar S; Chincholkar V; Mangalkar S
Indian J Pathol Microbiol; 2016; 59(4):496-498. PubMed ID: 27721280
[TBL] [Abstract][Full Text] [Related]
35. Ceftaroline fosamil: a cephalosporin with activity against methicillin-resistant Staphylococcus aureus.
Poon H; Chang MH; Fung HB
Clin Ther; 2012 Apr; 34(4):743-65. PubMed ID: 22444785
[TBL] [Abstract][Full Text] [Related]
36. [Ceftaroline, a new broad-spectrum cephalosporin in the era of multiresistance].
Horcajada JP; Cantón R
Enferm Infecc Microbiol Clin; 2014 Mar; 32 Suppl 2():1-7. PubMed ID: 24702972
[TBL] [Abstract][Full Text] [Related]
37. Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections in obese patients.
Evans JD; Udeani G; Cole P; Friedland HD
Postgrad Med; 2014 Sep; 126(5):128-34. PubMed ID: 25295657
[TBL] [Abstract][Full Text] [Related]
38. Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System.
Mootz ML; Britt RS; Mootz AA; Lee GC; Reveles KR; Evoy KE; Teng C; Frei CR
Hosp Pract (1995); 2019 Oct; 47(4):186-191. PubMed ID: 31578888
[No Abstract] [Full Text] [Related]
39. Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA.
Stryjewski ME; Jones RN; Corey GR
Diagn Microbiol Infect Dis; 2015 Mar; 81(3):183-8. PubMed ID: 25583130
[TBL] [Abstract][Full Text] [Related]
40. Ceftaroline fosamil: a new cephalosporin active against resistant Gram-positive organisms including MRSA.
Garrison MW; Kawamura NM; Wen MM
Expert Rev Anti Infect Ther; 2012 Oct; 10(10):1087-103. PubMed ID: 23167512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
